Late filing
Filing comparison
ORAMED PHARMACEUTICALS INC. told the SEC it could not file its quarterly report on time
Does not expect a significant change in results. Filed on the statutory due date.
(the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-Q.
Evidence
- Anticipates significant change
- No
- Days past due date
- 0
- Other periodic reports filed
- Yes
- Routine
- Yes
- Severity
- normal
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- (the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-Q.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.